|
NKTR | Nektar Therapeutics |
|
|
NKTR | Nektar Therapeutics |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.01 |
| Leverage | 71.76% |
| Market Cap | $ 10.8B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -120.8m |
| Margin | -192.74% |
Nektar Therapeutics is a biopharmaceutical company. The company is headquartered in San Francisco, California with additional operations in Huntsville, Alabama and Hyderabad, India.